Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double-stranded deoxyribonucleic acid (dsDNA) is the primary molecule for the storage and transmission of genetic information in all living organisms and many viruses. It consists of two polynucleotide chains coiled around each other to form a double helix, held together by hydrogen bonds between complementary nitrogenous bases. In a therapeutic context, dsDNA is a major target for various classes of antineoplastic agents, including alkylating agents that form covalent cross-links, intercalating agents that wedge between base pairs, and drugs that induce oxidative damage leading to strand breaks. These interactions disrupt essential cellular processes such as DNA replication and transcription, ultimately triggering apoptosis in rapidly dividing cancer cells. However, targeting DNA also poses significant safety challenges, including the risk of genotoxicity and the development of secondary cancers due to non-specific damage to healthy cells.
Intercalation, alkylation, cross-linking, and induction of strand breaks to inhibit replication and transcription.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic acid (double-stranded) (dsDNA).